Strides Pharma

With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio

Coal India reported a 0.8 per cent decline in consolidated profit to Rs 4,588.96 crore in the quarter ended March 2021 from Rs 4,625.7 crore in the same quarter ended last year

Strides Pharma: Prednisone drugs, also known as corticosteroids, are used as anti-inflammatory and immuno-suppressant medications for treating allergic disorders, skin conditions, ulcerative colitis and arthritis.

Strides Pharma shares surged as much as 5% after it got approval from USFDA for Butalbital, Acetaminophen, Caffeine, andCodeine Phosphate Capsules.

The company joins other drugmakers Glenmark and Strides Pharma Science that are conducting trials in India for potential drugs for COVID-19.

Bengaluru-based Strides Pharma Science has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country.

Strides Pharma shares zoomed more than 10 per cent on the BSE on Thursday after the company said that it has developedFavipiravir antiviral tablets for the treatment of COVID-19.

Glenmark Pharmaceuticals, which rose as much as 8.9 per cent to Rs 359, traded up 5.9 per cent at 9:37 am.

After a healthy correction from its all-time high, the Nifty has managed to take a support at its 100 weeks moving average which indicates a bounce back move in the Index.

US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records.

Citing IMS sales data, Strides Shasun said the US market for the approved product is approximately $17 million.

Shares of Strides Shasun were trading at Rs 1,077 apiece, up 0.13 per cent, from its previous close on the BSE

Strides Shasun on Thursday said it has received approval from the US Food and Drug Administration (FDA) for Polyethylene Elycol 3350, used for treating constipation.

Strides Shasun on Wednesday said it has received approval from the US Food and Drug Administration (FDA) for Ranitidine tablets used for treating intestinal and stomach ulcers and gastroesophageal reflux disease.

Drug firm Strides Shasun on Wednesday said it has completed acquisition of a controlling stake in Australia-based Generic Partners Holdings.

With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio

Coal India reported a 0.8 per cent decline in consolidated profit to Rs 4,588.96 crore in the quarter ended March 2021 from Rs 4,625.7 crore in the same quarter ended last year

Strides Pharma: Prednisone drugs, also known as corticosteroids, are used as anti-inflammatory and immuno-suppressant medications for treating allergic disorders, skin conditions, ulcerative colitis and arthritis.

Strides Pharma shares surged as much as 5% after it got approval from USFDA for Butalbital, Acetaminophen, Caffeine, andCodeine Phosphate Capsules.

The company joins other drugmakers Glenmark and Strides Pharma Science that are conducting trials in India for potential drugs for COVID-19.

Bengaluru-based Strides Pharma Science has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country.

Strides Pharma shares zoomed more than 10 per cent on the BSE on Thursday after the company said that it has developedFavipiravir antiviral tablets for the treatment of COVID-19.

Glenmark Pharmaceuticals, which rose as much as 8.9 per cent to Rs 359, traded up 5.9 per cent at 9:37 am.

After a healthy correction from its all-time high, the Nifty has managed to take a support at its 100 weeks moving average which indicates a bounce back move in the Index.

US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records.

Citing IMS sales data, Strides Shasun said the US market for the approved product is approximately $17 million.

Shares of Strides Shasun were trading at Rs 1,077 apiece, up 0.13 per cent, from its previous close on the BSE

Strides Shasun on Thursday said it has received approval from the US Food and Drug Administration (FDA) for Polyethylene Elycol 3350, used for treating constipation.

Strides Shasun on Wednesday said it has received approval from the US Food and Drug Administration (FDA) for Ranitidine tablets used for treating intestinal and stomach ulcers and gastroesophageal reflux disease.

Drug firm Strides Shasun on Wednesday said it has completed acquisition of a controlling stake in Australia-based Generic Partners Holdings.